oxazoles has been researched along with Fibrosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkhouri, N; Balendran, C; Billin, AN; Buchholtz, K; Damgaard, LH; Hassanein, T; Herring, R; Huss, RS; Kabler, H; Kayali, Z; Kjær, MS; Kohli, A; Loomba, R; Myers, RP; Noureddin, M; Zhu, Y | 1 |
| Cordaro, M; Crupi, R; Cuzzocrea, S; D'Amico, R; Di Paola, D; Di Paola, R; Fusco, R; Genovese, T; Gugliandolo, E; Impellizzeri, D; Interdonato, L; Peritore, AF; Siracusa, R | 1 |
| Caldez, MJ; Hunziker, W; Kaldis, P; Kausalya, PJ; Mohamed Ali, S; Ong, AGM; Van Hul, N; Woo, WL; Xu, J; Xu, S | 1 |
| Bailey, S; Billotte, S; Bordner, J; Fish, PV; Greiling, D; James, K; McElroy, A; Mills, JE; Reed, C; Webster, R | 1 |
| Liong, EC; Nanji, AA; Tipoe, GL; Xiao, J | 1 |
1 trial(s) available for oxazoles and Fibrosis
| Article | Year |
|---|---|
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial.
Topics: Azetidines; Double-Blind Method; Fibrosis; Glucagon-Like Peptides; Humans; Isobutyrates; Isonicotinic Acids; Non-alcoholic Fatty Liver Disease; Oxazoles; Pyrimidines; Treatment Outcome | 2022 |
4 other study(ies) available for oxazoles and Fibrosis
| Article | Year |
|---|---|
Chronic Exposure to Vinclozolin Induced Fibrosis, Mitochondrial Dysfunction, Oxidative Stress, and Apoptosis in Mice Kidney.
Topics: Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Body Weight; Caspase 3; Catalase; Creatinine; Fibrosis; Fungicides, Industrial; Glutathione; Glutathione Peroxidase; Kidney; Mice; Mitochondria; NF-E2-Related Factor 2; Nitrogen; Oxazoles; Oxidative Stress; RNA, Messenger; Sirtuin 1; Sirtuin 3; Superoxide Dismutase; Urea | 2022 |
Protective Functions of ZO-2/Tjp2 Expressed in Hepatocytes and Cholangiocytes Against Liver Injury and Cholestasis.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 11; Bile Acids and Salts; Bile Canaliculi; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Cholestasis; Cholic Acid; Claudin-1; Cytochrome P450 Family 2; Cytoskeletal Proteins; Epithelial Cells; Female; Fibrosis; Genetic Predisposition to Disease; Hepatocytes; Male; Membrane Proteins; Mice; Mice, Knockout; Mutation; Oxazoles; Permeability; Protective Factors; RNA, Messenger; Steroid Hydroxylases; Tight Junctions; Ursodeoxycholic Acid; Zonula Occludens-2 Protein | 2021 |
Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.
Topics: Administration, Cutaneous; Bone Morphogenetic Protein 1; Cell Line, Tumor; Chemistry, Pharmaceutical; Cicatrix; Cicatrix, Hypertrophic; Drug Design; Epidermis; Fibrosis; Humans; Hydroxamic Acids; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Oxazoles | 2008 |
Thromboxane inhibitors attenuate inflammatory and fibrotic changes in rat liver despite continued ethanol administrations.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System Depressants; Cyclooxygenase 2; Endotoxins; Ethanol; Fatty Liver, Alcoholic; Fibrosis; Lipid Peroxidation; Liver; Male; NF-kappa B; Oxazoles; Pyridines; Rats; Rats, Wistar; Receptors, Thromboxane; RNA, Messenger; Thromboxane-A Synthase; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2013 |